Exploratory Study to Assess the Pharmacokinetics of AZD5985

Inclusion Criteria: * Provision of signed, written and dated informed consent prior to any study specific procedures. * Healthy male subjects aged 18 to 45 years (inclusive). * Have a body mass index (BMI) between 19 and 30 kg/m2 and weigh at least 50 kg and no more than 100 kg. * Be non-smoker or ex-smoker who has stopped smoking (or using other nicotine products) for \>6 months prior to study start. Exclusion Criteria: * History or presence of any clinically significant disease or disorder in the opinion of the investigator. * Any clinically relevant abnormal findings in physical examination, clinical chemistry, haematology, urinalysis, vital signs or ECG at baseline in the opinion of the investigator. * Participation in another investigational drug study within 3 months before Visit 2 or participation in a method development study (no drug) 1 month prior to Visit 2